[go: up one dir, main page]

WO2003031984A3 - Verfahren zur sequenzanalyse von polypeptiden - Google Patents

Verfahren zur sequenzanalyse von polypeptiden Download PDF

Info

Publication number
WO2003031984A3
WO2003031984A3 PCT/EP2002/011257 EP0211257W WO03031984A3 WO 2003031984 A3 WO2003031984 A3 WO 2003031984A3 EP 0211257 W EP0211257 W EP 0211257W WO 03031984 A3 WO03031984 A3 WO 03031984A3
Authority
WO
WIPO (PCT)
Prior art keywords
halogen
group containing
polypeptides
alkyl
analysing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/011257
Other languages
English (en)
French (fr)
Other versions
WO2003031984A2 (de
Inventor
Christian Wurzel
Ralf Krueger
Lynar Barbara Zu
Barbara Popke
Liebold Brigitte Wittmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CONSEQUENCE GmbH
Original Assignee
CONSEQUENCE GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CONSEQUENCE GmbH filed Critical CONSEQUENCE GmbH
Priority to AU2002346975A priority Critical patent/AU2002346975A1/en
Publication of WO2003031984A2 publication Critical patent/WO2003031984A2/de
Publication of WO2003031984A3 publication Critical patent/WO2003031984A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6818—Sequencing of polypeptides
    • G01N33/6824—Sequencing of polypeptides involving N-terminal degradation, e.g. Edman degradation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die vorliegende Erfindung betrifft. die Verwendung eines Halogen-substituierten Phenylisothiocyanates der Formel worin R, bis RS jeweils unabhängig voneinander ausgewählt sind aus der Gruppe, die Wasserstoff, Halogen, Alkyl und Halogenalkyl umfasst, wobei Halogen ausgewählt ist aus der Gruppe, die Fluor, Chlor, Brom and Jod umfasst, und Alkyl ausgewählt ist aus der Gruppe, die Methyl, Ethyl, n-Propyl und Isopropyl umfasst; unter der Voraussetzung, dass wenigstens einer der Reste R, bis Rs ein Halogen ist. und/oder ein Halogen enthalt, zur Derivatisierung und/oder zum Nachweis von primären und/oder sekundären Aminen in der Sequenzanalyse von Polypeptiden.
PCT/EP2002/011257 2001-10-08 2002-10-08 Verfahren zur sequenzanalyse von polypeptiden Ceased WO2003031984A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002346975A AU2002346975A1 (en) 2001-10-08 2002-10-08 Method for analysing the sequence of polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2001149568 DE10149568A1 (de) 2001-10-08 2001-10-08 Verfahren zur Sequenzanalyse von Polypeptiden
DE10149568.4 2001-10-08

Publications (2)

Publication Number Publication Date
WO2003031984A2 WO2003031984A2 (de) 2003-04-17
WO2003031984A3 true WO2003031984A3 (de) 2003-07-31

Family

ID=7701781

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/011257 Ceased WO2003031984A2 (de) 2001-10-08 2002-10-08 Verfahren zur sequenzanalyse von polypeptiden

Country Status (3)

Country Link
AU (1) AU2002346975A1 (de)
DE (1) DE10149568A1 (de)
WO (1) WO2003031984A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295406B1 (de) 2008-05-30 2014-04-23 Takeda Pharmaceutical Company Limited Heterocyclische verbindung
PT3210973T (pt) 2014-10-24 2021-02-12 Takeda Pharmaceuticals Co Compostos de heteroarilo para o tratamento de doenças oftálmicas

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1528249A (fr) * 1966-06-22 1968-06-07 Ciba Geigy Agents de destruction des acarides et des mollusques
EP0609450A1 (de) * 1992-07-27 1994-08-10 Seiko Instruments Inc. Verfahren zum hochempfindlichen nachweis von aminosäurederivaten
US5534440A (en) * 1991-02-22 1996-07-09 Biomedical Research Centre Limited Compounds and methods for sequencing amino acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608488A1 (de) * 1975-03-05 1976-09-16 Ciba Geigy Ag Iso(thio)harnstoffe
IT1237964B (it) * 1990-02-01 1993-06-19 Minnesota Mining & Mfg Elementi fotografici agli alogenuri d'argento sensibili all'infrarosso

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1528249A (fr) * 1966-06-22 1968-06-07 Ciba Geigy Agents de destruction des acarides et des mollusques
US5534440A (en) * 1991-02-22 1996-07-09 Biomedical Research Centre Limited Compounds and methods for sequencing amino acids
EP0609450A1 (de) * 1992-07-27 1994-08-10 Seiko Instruments Inc. Verfahren zum hochempfindlichen nachweis von aminosäurederivaten

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALLEN G.: "Laboratoty techniques in biochemistry and molecular biology: sequencing of proteins and peptides.", 1981, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, XP002236295 *
NAGARAJAN K ET AL: "ANTIIMPLANTATION AGENTS: PART I-1-ARYLTHIOSEMICARBAZIDES", INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC, INCL. MEDICINAL, PUBLICATIONS & INFORMATIONS DIRECTORATE, NEW DELHI, IN, vol. 23, no. 12, December 1984 (1984-12-01), pages 1243 - 1257, XP000946159, ISSN: 0019-5103 *
WALKER J M: "THE DANSYL-EDMAN METHOD FOR PEPTIDE SEQUENCING", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS INC., CLIFTON, NJ, US, vol. 32, 1994, pages 329 - 334, XP009006185 *

Also Published As

Publication number Publication date
WO2003031984A2 (de) 2003-04-17
AU2002346975A1 (en) 2003-04-22
DE10149568A1 (de) 2003-04-24

Similar Documents

Publication Publication Date Title
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
CY1110362T1 (el) Ν-(2-αρυλαιθυλο)βενζυλαμινες ως ανταγωνιστες του 5-ητ6 υποδοχεα
ATE356119T1 (de) Pyrimidinone als melanin concentrating hormone receptor 1
NO20012701L (no) Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter
WO2003014325A3 (en) Protein design automation for protein libraries
WO2003084936A8 (en) Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
AU2005240213A8 (en) Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
DK342684A (da) Vandige proteinoploesninger, som er bestandige over for denaturering, fremgangsmaade til deres fremstilling og deres anvendelse
NO922524D0 (no) Pyrimidinderivater, deres fremstilling og anvendelse
BRPI0407841A (pt) inibidores heterocìclicos de quinase
DK1279665T3 (da) Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser
DE60336735D1 (de) Neue biologischaktive molekü le
NO331195B1 (no) Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter.
WO2002068453A3 (en) Methods and compositions for the construction and use of fusion libraries using computational protein design methods
WO2003031984A3 (de) Verfahren zur sequenzanalyse von polypeptiden
DK1438294T3 (da) Fremkalderkomponenter og deres anvendelse til farvning af keratinfibre
NO20045487L (no) Anvendelse av fluor NMR for hoy gjennomlopsscreening
AU2002356319A1 (en) Dna minor groove binding compounds
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
WO2003049541A3 (en) Nematicidal trifluorobutenyl imidazole thioether derivatives
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
DK0998470T3 (da) Fremgangsmåde til fremstilling af aminderivater af alkyloxyfuranon, forbindelser fremstillet ved denne fremgangsmåde og anvendelse af disse forbindelser
ATE282608T1 (de) Chinoxalindionen
DK1178985T3 (da) Substituerede thienocycloalk(en)ylamino-1,3,5-triaziner
DK0547523T3 (da) Ethanol-addukter af 6-sulfonylsubstituerede 3-hydroxychromaner og deres anvendelse som inhalationsmiddel ved sygdomme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP